For: | Bhanderi H, Khalid F, Bodla ZH, Muhammad T, Du D, Meghal T. Autoimmune diabetes from pembrolizumab: A case report and review of literature. World J Clin Oncol 2023; 14(11): 535-543 [PMID: 38059185 DOI: 10.5306/wjco.v14.i11.535] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v14/i11/535.htm |
Number | Citing Articles |
1 |
Santino Caserta, Gabriella Cancemi, Giuseppe Murdaca, Fabio Stagno, Mario Di Gioacchino, Sebastiano Gangemi, Alessandro Allegra. The Effects of Cancer Immunotherapy on Fertility: Focus on Hematological Malignancies. Biomedicines 2024; 12(9): 2106 doi: 10.3390/biomedicines12092106
|
2 |
Li-Bo Tang, Ying-Long Peng, Ji Chen, Jia-Ting Li, Mei-Mei Zheng, Lv Wu, Chang Lu, Xue-Wu Wei, Dong-Xuan Cai, Zhi Guo, Zi-Rui Ren, Si-Di Lv, Yu Deng, Zhi-Hong Chen, Chong-Rui Xu, Qing Zhou. Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer. Nature Reviews Clinical Oncology 2025; doi: 10.1038/s41571-025-01029-7
|
3 |
Pei Zhang, Chenyan Zhang, Xiaoying Li, Chen Chang, Cailing Gan, Tinghong Ye, Dan Cao. Immunotherapy for gastric cancer: Advances and challenges. MedComm – Oncology 2024; 3(4) doi: 10.1002/mog2.92
|
4 |
Jose Angel Garcia, Diego Alcaraz, Esther Holgado, Felipe Couñago. Pembrolizumab autoimmune related diabetes: Moving forward, keep learning. World Journal of Clinical Oncology 2024; 15(5): 576-579 doi: 10.5306/wjco.v15.i5.576
|